Edition:
United States

Ibio Inc (IBIO.A)

IBIO.A on American Stock Exchange

0.37USD
4:00pm EDT
Change (% chg)

$0.00 (+0.16%)
Prev Close
$0.37
Open
$0.37
Day's High
$0.37
Day's Low
$0.37
Volume
16,087
Avg. Vol
10,774
52-wk High
$0.80
52-wk Low
$0.34

Latest Key Developments (Source: Significant Developments)

Ibio appoints James Mullaney as CFO
Monday, 6 Mar 2017 06:36pm EST 

Ibio Inc : On March 1, co appointed James P. Mullaney to serve as chief financial officer of company, replacing Mark Giannone .Ibio Inc - Giannone resigned effective March 1, 2017 to pursue other career opportunities - SEC filing.  Full Article

Ibio receives FDA orphan drug designation for fibrosis product
Tuesday, 5 Jul 2016 08:31am EDT 

Ibio Inc : Ibio Inc receives FDA orphan drug designation for fibrosis product candidate .FDA has granted orphan drug designation to Ibio's investigational biotherapeutic product, ibio-cfb03, for treatment of systemic sclerosis.  Full Article

Ibio says files for non-timely 10-Q at U.S. SEC - SEC Filing
Monday, 16 May 2016 06:23pm EDT 

Ibio Inc : Says files for non-timely 10-q at u.s. Sec - sec filing .Says is experiencing delays in collection and compilation of certain information required to be included in the form 10-q.  Full Article

iBio, Inc to receive US patent for Influenza Therapeutic
Tuesday, 11 Aug 2015 08:31am EDT 

iBio, Inc:Received notice that its application for a U.S. patent for a monoclonal antibody targeting influenza is scheduled to result in issuance of a new patent on Aug. 26.  Full Article

More From Around the Web

BRIEF-Ibio appoints James Mullaney as CFO

* On March 1, co appointed James P. Mullaney to serve as chief financial officer of company, replacing Mark Giannone